ClinicalTrials.gg

DrugBiological

Rindopepimut clinical trials

studies test it
4
open now
0
in phase 3
1
first study started
2007

How studies write it

Studies that test it under each name

Name

Rindopepimut (CDX-110) with GM-CSF
2
Rindopepimut
1

Studies by the year they started

4 studies that test it; most in 2011 (3)

Studies that test rindopepimut, by start year
YearStudies
20071
20113

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
2
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 3 · Other 1

Celldex Therapeutics (3) · Paul Graham Fisher (1)

Often tested with

Tested in the same studies.

Keyhole limpet hemocyanin (1) · Granulocyte-Macrophage Colony-Stimulating Factor (1) · Temozolomide (1)

Studies

Open first, then newest update. How each study uses rindopepimut is read from its arms, and is right about nine times in ten.

Testing it · 4

Codes

What other systems call rindopepimut · ClinicalTrials.gg INT005830

  • MeSH (NLM) C558237rindopepimutConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) K3L4X0501FRINDOPEPIMUTConfirmed FDA, NLM, Wikidata
  • Wikidata Q25104603rindopepimutConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C69076RindopepimutOne source FDA
  • DrugBank DB05374One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.